Grøndahl-Hansen J, Nielsen L S, Kristensen P, Grøndahl-Hansen V, Andreasen P A, Danø K
Br J Dermatol. 1985 Sep;113(3):257-63. doi: 10.1111/j.1365-2133.1985.tb02076.x.
Extracts of scale from four patients with psoriasis all contained plasminogen activator. All plasminogen activator activity was of the tissue-type (t-PA) as judged from the following criteria: all enzyme activity was inhibited by a monoclonal antibody against human t-PA, while there was no measurable inhibition by a monoclonal antibody against human urokinase-type plasminogen activator (u-PA); as determined by zymography the extracts contained one type of plasminogen activator which had an electrophoretic mobility identical to that of purified t-PA; this plasminogen activator was removed by passage through a Sepharose column coupled with a monoclonal antibody against t-PA, but not by passage through a column coupled with a monoclonal antibody against u-PA. On a molar basis the detection limit for u-PA was 10% of that of t-PA present.
四名银屑病患者鳞屑提取物均含有纤溶酶原激活物。根据以下标准判断,所有纤溶酶原激活物活性均为组织型(t-PA):所有酶活性均被抗人t-PA单克隆抗体抑制,而抗人尿激酶型纤溶酶原激活物(u-PA)单克隆抗体未检测到抑制作用;通过酶谱法测定,提取物含有一种纤溶酶原激活物,其电泳迁移率与纯化的t-PA相同;该纤溶酶原激活物通过与抗t-PA单克隆抗体偶联的琼脂糖柱时被去除,但通过与抗u-PA单克隆抗体偶联的柱时未被去除。以摩尔计,u-PA的检测限为存在的t-PA的10%。